Skip to main content

Table 5 Significant correlations

From: Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review

 

No. of pts.

Spearmen-Rho

p-value

Quality of life

   

Health status

111

0.882

0.000

ICIQ (1)

111

−0.211

0.027

IPSS (2)

104

−0.204

0.037

Urethral D30 (3)

   

Volume of prostate

162

−0.326

0.000

IPSS at survey

   

IPSS (preimplant)

103

0.287

0.003

Seed dislocation/loss

  

V100 (4)

163

−0.262

0.001

D90 (5)

163

−0.190

0.015

  1. (1) ICIQ: international consultation on incontinence modular questionnaire.
  2. (2) IPSS: international prostate symptom score.
  3. (3) D30: dose to 30% of the urethra.
  4. (4) V100: volume of the prostate receiving 100% of the prescription dose.
  5. (5) D90: dose to 90% of the prostate.